Locations:
Abu Dhabi|Canada|Florida|London|Nevada|Ohio|
Gray gradientGray gradient
Cleveland Clinic icon
Consult QD logo
Search IconSearch

Heart, Vascular and Thoracic

histopathologic image of tissue from a hypertrophied heart
November 22, 2024/Heart, Vascular and Thoracic/Clinical Cardiology

Myocardium Histology Predicts Long-Term Outcomes of Obstructive Hypertrophic Cardiomyopathy

High composite score in myectomy specimens signals worse prognosis

Obstructive hypertrophic cardiomyopathy
November 21, 2024/Heart, Vascular and Thoracic/Clinical Cardiology

REMS Update: Mavacamten Still Effective in Treating Real-World Patients With HCM

Few patients report left ventricular dysfunction or heart failure after one year

cardiac MRI showing obstructive hypertrophic cardiomyopathy
November 20, 2024/Heart, Vascular and Thoracic/Clinical Cardiology

Final VALOR-HCM Report: At 128 Weeks, Mavacamten Sustains Gains in HCM Patients

Avoidance of septal reduction therapy continues while LVEF dysfunction remains infrequent

edge of an apolipoprotein particle
November 19, 2024/Heart, Vascular and Thoracic/Preventive Cardiology

Small-Interfering RNA Shows Cumulative Lp(a) Reduction With Successive Doses

Phase 2 trial of zerlasiran yields first demonstration of longer effect with each dose of an siRNA

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

medical device deployed in the heart's left atrial appendage
November 18, 2024/Heart, Vascular and Thoracic/Electrophysiology

LAA Occlusion Compares Favorably With Newer Oral Anticoagulants After AF Ablation

OPTION trial demonstrates significantly less bleeding risk with comparable efficacy

deployment of balloon aortic valvuloplasty device in the heart
November 15, 2024/Heart, Vascular and Thoracic/Clinical Cardiology

Outcomes of Contemporary Therapy for Cardiogenic Shock Due to Severe Aortic Stenosis

Aortic valve replacement is best option for lowering mortality in this high-risk population

occluded pulmonary vein on angiography
November 11, 2024/Heart, Vascular and Thoracic/Interventional Cardiology

Adding Drug-Coated Balloon Angioplasty to Stenting Reduces Pulmonary Vein Restenosis

Novel approach outperforms standard of care for post-PVI stenosis and occlusion

echocardiograms showing heart valve disease
November 8, 2024/Heart, Vascular and Thoracic/Education

Structural Valve Imaging Summit Returns With State-of-the-Art Program, Abundant Expert Interaction

27th offering of this CME favorite to be held March 6-9 in Hollywood, Florida

stylized heart and lungs with text overlay
November 7, 2024/Heart, Vascular and Thoracic/Outcomes

Vitals: Outcomes in Adult Cardiac Surgery and Ischemic and Vascular Disease

A graphical recap of our recent data from some key cardiovascular areas

heller myotomy operation
November 5, 2024/Heart, Vascular and Thoracic/Thoracic Surgery & Lung Transplant

Heller Myotomy for Esophageal Achalasia: 15-Year Freedom From Reintervention Is > 80%

25-year series of over 1,000 patients reveals good long-term palliation, esophageal preservation

BackPage 1 of 104Next

Advertisement

Ad